Evidence map›Paper›PMID 21119608›Full record

ReviewNature reviews. Rheumatology2011

Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Mohit Kapoor, Johanne Martel-Pelletier, Daniel Lajeunesse, Jean-Pierre Pelletier, Hassan Fahmi

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Rheumatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1,456 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,456citing papers in PubMed, 4 pooled it
38.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02964624 nacompletednot on this mapstarted 2018, after this paper: background citation

Response of Osteoarthritis Biomarkers After a Rehabilitation Program

TypeinterventionalSponsorHospital Israelita Albert EinsteinRan2018 to 2019Enrolled65ConditionsOsteoarthritisArmsRehabilitation
NCT03850080 phase2 / phase3completednot on this mapstarted 2017, after this paper: background citation

Autologous Conditioned Serum: Functional and Clinical Results Using a Novel Disease Modifying Agent for the Management of Knee Osteoarthritis

TypeinterventionalSponsorOspedale San RaffaeleRan2017 to 2018Enrolled15ConditionsKnee Osteoarthritis, Osteoarthritis, Knee, Cartilage DegenerationArmsAutologous Conditioned Serum
3 · Its place in the literature

Who cites it

1,456 citing papers in PubMed, 4 syntheses or guidelines pooled it, 2,677 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

1,396 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohit KapoorOsteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, 1560 Sherbrooke Street East, Montreal, QC H2L 4M1, Canada.
Johanne Martel-Pelletier
Daniel Lajeunesse
Jean-Pierre Pelletier
Hassan Fahmi
Université de Montréal · CAHôpital Notre-Dame · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is associated with cartilage destruction, subchondral bone remodeling and inflammation of the synovial membrane, although the etiology and pathogenesis underlying this debilitating disease are poorly understood. Secreted inflammatory molecules, such as proinflammatory cytokines, are among the critical mediators of the disturbed processes implicated in OA pathophysiology. Interleukin (IL)-1β and tumor necrosis factor (TNF), in particular, control the degeneration of articular cartilage matrix, which makes them prime targets for therapeutic strategies. Animal studies provide support for this approach, although only a few clinical studies have investigated the efficacy of blocking these proinflammatory cytokines in the treatment of OA. Apart from IL-1β and TNF, several other cytokines including IL-6, IL-15, IL-17, IL-18, IL-21, leukemia inhibitory factor and IL-8 (a chemokine) have also been shown to be implicated in OA and could possibly be targeted therapeutically. This Review discusses the current knowledge regarding the role of proinflammatory cytokines in the pathophysiology of OA and addresses the potential of anticytokine therapy in the treatment of this disease.

Indexed as

Cartilage, ArticularDisease ProgressionHumansInterleukin-1betaInterleukin-6OsteoarthritisTumor Necrosis Factor-alphaInterleukin-1betaInterleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID21119608
OpenAlexW2038773696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.